Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 7671237.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Human leukemias with 11q23 translocations occur sporadically and after cancer treatment with DNA topoisomerase II-targeted drugs. To investigate this process, we examined DNA topoisomerase II cleavage in vitro in subclones of the normal 11q23 genomic homologue and a t(9;11) translocation breakpoint junction. Cleavage was assayed with limiting dilutions of enzyme in the presence or absence of epipodophyllotoxin and ATP. The strongest sites of cleavage coincided with the t(9;11) breakpoint site and two other translocation breakpoint sites within the normal homologue. These results support the involvement of DNA topoisomerase II in the translocation process at chromosome band 11q23.
Medical subject headings
- Chromosomes, Human, Pair 11
- Chromosomes, Human, Pair 9
- DNA Topoisomerases, Type II
- Proto-Oncogenes
- Transcription Factors
- Translocation, Genetic